Operation Whole Health
Operation Whole Health · Readiness & Informed-Consent Standard

Modality Education Library

An honest, patient-facing education brief for every medicine — attaches to the universal Patient & Caregiver courses
Document: DRAFT v0.1 — for clinician-of-record review
Companion to: the universal Patient Track, Caregiver Track & Protocol v1
How this works

One honest brief per medicine

The Patient and Caregiver courses teach the universal core — consent, readiness, mindset, integration, safety — that's true no matter which medicine. This library adds the medicine-specific half: a plain-language brief for each modality, so a veteran preparing for ketamine or MDMA is served just as honestly as one preparing for ibogaine.

Evidence key: Established · Plausible · Hypothesis · Clinician sign-off
⚑ Draft for review. Every brief here informs consent and touches medical risk — each must be verified and signed by a named licensed physician before a patient sees it, and defers to the treating clinic on all clinical decisions. COI disclosed: OWH develops nutritional prep protocols/products; this education supports — never replaces — a clinic's own care and consent.
The scope

Master list of modalities

The full landscape, organized by class — this is what "the standard for everything" covers, and how any future medicine slots in.

MedicineBeing explored forLegal status (US)Signature risk
Classic psychedelics (serotonergic, 5-HT2A)
PsilocybinDepression, alcohol use, PTSD, end-of-life distressSchedule I (trials; some state programs)Psychological (psychosis/bipolar); transient BP/HR
LSDAnxiety, depressionSchedule IVery long duration; psychological; HPPD
DMT / AyahuascaDepression, traumaSchedule I (some religious exemptions)Rapid intensity; cardiovascular; ayahuasca is an MAOI (major interactions)
5-MeO-DMTDepression, addictionSchedule IExtreme intensity; physical/airway safety
Mescaline (peyote/San Pedro)Trauma, addictionSchedule I (peyote exemptions)Long duration; cardiovascular
Entactogens / empathogens
MDMAPTSDSchedule I (late-stage trials)Serotonin syndrome; hyperthermia; hyponatremia
Dissociatives (NMDA antagonists)
Ketamine / EsketamineDepression, suicidality, PTSDSchedule III (ketamine off-label; esketamine FDA-approved)Bladder toxicity; dependence; dissociation; BP
Oneirogen / iboga alkaloids
IbogaineOpioid/other addiction, TBI, PTSDSchedule ICardiac — QT prolongation, fatal arrhythmia
Cannabinoids
Cannabis (THC/CBD)PTSD, pain, sleepSchedule I federally; many states legalDose-dependent psychosis; cardiovascular; dependence
Atypical plant / opioid-adjacent
Kratom (mitragynine)Opioid withdrawal, pain, moodUnscheduled federally; varies by stateDependence/withdrawal; hepatotoxicity; toxicity
Extensible: new medicines are added by class — each gets a full brief on the same template. Full briefs for the seven most-used are below; the remaining classic psychedelics (DMT/ayahuasca, 5-MeO-DMT, mescaline) and esketamine follow the same structure and are next in the build queue.
The briefs

Patient education — by medicine

Ibogaine Schedule I

Oneirogen / iboga alkaloid · long, single-session experience

What it is & how it's thought to work

A plant-derived compound that acts on many brain systems at once and raises BDNF (a growth signal for neurons)3; used mainly for addiction and, increasingly, TBI/PTSD in veterans1.

Why people try it Plausible

A Stanford study of 30 Special Operations veterans reported large improvements in disability, PTSD, depression, and anxiety — striking, but early and open-label1.

The honest risks Established

Its defining danger is the heart: it prolongs the QT interval and can cause fatal arrhythmia, at normal doses, even without prior heart disease, with risk lasting days2,3,4. Your body's CYP2D6 enzyme also determines your exposure — some people get double the dose effect5.

Non-negotiable prep: ECG/QTc, electrolytes, medication reconciliation (some SSRIs are dangerous with it), continuous cardiac monitoring. If a provider skips the cardiac screen, walk away.
Caregiver: watch for fainting, chest pain, or irregular heartbeat during and for days after; know 988 and 911.

MDMA Schedule I · late trials

Entactogen · heart-opening, emotionally engaged experience

What it is & how it's thought to work

A compound that increases serotonin and promotes feelings of safety and connection, studied primarily to help people process trauma in PTSD therapy.

Why people try it Plausible

It appears to lower fear and defensiveness enough to make trauma processing possible; late-stage trials have targeted PTSD.

The honest risks Established

Because it floods serotonin, combining it with SSRIs, SNRIs, or MAOIs risks serotonin syndrome — a medical emergency. It can also cause dangerous overheating, low sodium from over-drinking water, and raises blood pressure/heart rate6.

Prep specifics: cardiovascular check; a prescriber-supervised taper of serotonergic meds beforehand; temperature and sensible hydration during sessions.
Caregiver: watch for overheating, confusion, or rigidity; make sure the team knows every serotonergic medication.

Ketamine / Esketamine Schedule III · legal off-label

Dissociative (NMDA) · shorter sessions, often repeated

What it is & how it's thought to work

An anesthetic at higher doses; at lower doses it produces a dissociative state and rapidly boosts neuroplasticity, used for depression, suicidality, and PTSD. Esketamine (a nasal form) is FDA-approved for treatment-resistant depression.

Why people try it Plausible

It can lift severe depression and suicidal thinking quickly — sometimes within hours — which is why it's the most medically accessible of these options.

The honest risks Established

Acute dissociation and a temporary rise in blood pressure/heart rate. With repeated or frequent use, two concerns grow: bladder damage ("ketamine cystitis")7 and dependence/abuse potential.

Prep specifics: cardiovascular check; if you'll do repeated courses, baseline urinary symptoms and monitor them; honest substance-use screening.
Caregiver: they should not drive after; watch for urinary symptoms and any pattern of wanting more, more often.

Psilocybin Schedule I · trials / some states

Classic psychedelic (5-HT2A) · single deep session

What it is & how it's thought to work

The active compound in "magic mushrooms," which acts on serotonin 5-HT2A receptors and promotes neuroplasticity; studied for depression, alcohol use, PTSD, and end-of-life distress.

Why people try it Plausible

Controlled trials show real benefit — for example, a randomized trial in alcohol use disorder found significantly fewer heavy-drinking days, with no serious adverse events from psilocybin8.

The honest risks Established

Medical risk in controlled settings is relatively low8,10, but the psychological risk is real — it can destabilize people with a history of psychosis or bipolar disorder — and it transiently raises blood pressure/heart rate6. Rarely, lingering visual changes (HPPD) occur10.

Prep specifics: careful psychiatric screening; cardiovascular caution if you have heart disease; a prepared setting and a real integration plan.
Caregiver: your steady presence matters most here; watch for lasting disconnection from reality afterward.

LSD Schedule I

Classic psychedelic (5-HT2A) · very long session

What it is & how it's thought to work

A potent, long-acting serotonergic psychedelic studied for anxiety and depression; mechanism is similar to psilocybin but the experience lasts much longer (up to ~12 hours).

The honest risks Established

Medical toxicity is generally low in controlled settings, but the very long duration magnifies psychological demand; risks include destabilization in vulnerable people, HPPD, and transient high blood pressure10.

Prep specifics: the same psychiatric and cardiovascular screening as psilocybin, plus planning for a long day — setting, support, and monitoring across many hours.
Caregiver: prepare for a long haul; steadiness and patience over many hours is the job.

Cannabis (THC / CBD) Schedule I federal · many states legal

Cannabinoid · widely used, dose- and strain-dependent

What it is & how it's thought to work

Acts on the body's cannabinoid system; THC is intoxicating, CBD is not. Used by many veterans for PTSD symptoms, pain, and sleep — legally in many states, though evidence for PTSD specifically is still limited.

The honest risks Established

The clearest risk is psychosis: reviews show a dose-dependent increased risk, earlier onset, and worse course — especially in those with a personal or family predisposition9. Also: increased heart rate/cardiovascular strain, dependence, and, with heavy chronic use, cannabinoid hyperemesis.

Prep specifics: psychiatric screening (psychosis/bipolar/family history); cardiovascular caution; honest look at use patterns and dependence.
Caregiver: watch for paranoia or disordered thinking, and for a creeping pattern of heavier use.

Kratom (Mitragynine) Unscheduled federally · varies by state

Atypical plant · opioid-like activity · sold OTC

What it is & how it's thought to work

A Southeast Asian plant whose alkaloids act partly on opioid receptors; often self-used for opioid withdrawal, pain, and mood. It is not a psychedelic — but it's widely used in this same population, so honest education matters.

The honest risks Established

It carries a real risk of dependence and withdrawal, liver injury, seizures, and life-threatening toxicity — especially when combined with other drugs11. "Natural" does not mean safe, and it is unregulated, so product strength varies wildly.

Prep specifics: liver labs; dependence/withdrawal screening; careful drug-interaction review; honest counseling about its unregulated, variable nature.
Caregiver: watch for withdrawal, escalating use, and signs of liver trouble (yellowing, dark urine, belly pain).

Operation Whole Health — Patriot-founded 501(c)(3). Modality Education Library, DRAFT v0.1 — not for patient use until each brief is signed by a named licensed physician.

Disclosures & limits: Educational only; not medical advice, not a treatment protocol, and not an endorsement of any Schedule I substance or unregulated product. Substances named here carry serious, sometimes fatal risks and varying legal status; all care and clinical decisions belong to qualified treating clinicians. OWH develops nutritional prep protocols/products (conflict disclosed); this supports — never replaces — a clinic's own care and consent. Human evidence retrieved from PubMed; see references.

Crisis: dial 988, then press 1.

References

Sources

  1. Cherian KN, et al. Magnesium–ibogaine therapy in veterans with TBI. Nature Medicine, 2024. DOI
  2. Alper K, et al. hERG Blockade by Iboga Alkaloids. Cardiovascular Toxicology, 2016. DOI
  3. Litjens RPW, Brunt TM. How toxic is ibogaine? Clinical Toxicology, 2016. DOI
  4. Brunt TM. Ibogaine and cardiovascular complications. Addiction, 2026. DOI
  5. Glue P, et al. CYP2D6 activity & ibogaine PK/PD. J Clinical Pharmacology, 2015. DOI
  6. Johnston CB, et al. Psychedelic-assisted therapies in older adults (MDMA/psilocybin cardiovascular effects). Am J Geriatric Psychiatry, 2022. DOI
  7. Baker SC, et al. Ketamine-induced urothelial toxicity (ketamine cystitis). American J Pathology, 2016. DOI
  8. Bogenschutz MP, et al. Psilocybin-assisted therapy for alcohol use disorder (RCT). JAMA Psychiatry, 2022. DOI
  9. Hasan A, et al. Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci, 2019. DOI
  10. Schlag AK, et al. Adverse effects of psychedelics: from anecdotes to systematic science. J Psychopharmacology, 2022. DOI
  11. Sethi R, et al. Kratom (Mitragyna speciosa): Friend or Foe? Prim Care Companion CNS Disord, 2020. DOI